J Korean Assoc Oral Maxillofac Surg.  2014 Oct;40(5):240-245. 10.5125/jkaoms.2014.40.5.240.

Angiokeratoma circumscriptum of the buccal mucosa: a case report and literature review

Affiliations
  • 1Department of Oral and Maxillofacial Surgery, Gyeongsang National University School of Medicine, Jinju, Korea. parkbw@gnu.ac.kr

Abstract

Angiokeratoma is a benign cutaneous lesion of the capillaries, presenting as dilated vessels in the upper part of the dermis. Although this disorder is classified into various types and has been occasionally reported in the skin of the scrotum or extremities, the involvement of the oral cavity mucosa has been rarely reported. The present study reports a case of angiokeratoma circumscriptum in the buccal mucosa. The expression of vascular endothelial growth factor (VEGF) and both of its receptors (VEGFR-1 and VEGFR-2) was demonstrated by immunohistochemistry in the endothelial cells lining the dilated vessels. The expression of VEGFR-2 was higher than that of VEGFR-1 in the endothelial cells in the lesion, indicating an increased rate of endothelial cell proliferation within the lesion. Interestingly, some of the endothelial cells co-expressed VEGF and its two receptors. These results suggest that endothelial cells in the pathologically dilated vessels possess VEGF autocrine growth activity involved in vasculogenesis and maintenance in angiokeratoma lesions. To our knowledge, this is the second report published on isolated oral angiokeratoma confined to the buccal mucosa and the first case report on angiokeratoma circumscriptum involving the buccal mucosa.

Keyword

Angiokeratoma circumscriptum; Buccal mucosa

MeSH Terms

Angiokeratoma*
Capillaries
Dermis
Endothelial Cells
Extremities
Immunohistochemistry
Mouth
Mouth Mucosa*
Mucous Membrane
Scrotum
Skin
Vascular Endothelial Growth Factor A
Vascular Endothelial Growth Factor Receptor-1
Vascular Endothelial Growth Factor Receptor-2
Vascular Endothelial Growth Factor A
Vascular Endothelial Growth Factor Receptor-1
Vascular Endothelial Growth Factor Receptor-2

Figure

  • Fig. 1 Preoperative clinical and magnetic resonance imaging (MRI) findings. A. Primary lesions presented as multiple, small, irregular, raised lesions on the right side of the buccal mucosa. B, C. MRI shows an ill-defined heterogeneously enhanced lesion on the right side of the cheek (arrows).

  • Fig. 2 H&E staining showing the histopathological features of the angiokeratoma circumscriptum lesion on the buccal mucosa (scale bars=200 µm). A. Low-power magnification shows epithelial hyperkeratosis, acanthosis, and large cystic lesions. B. High-power magnification shows erythrocytes filling the dilated cystic lesion. These pathological features are consistent with those of angiokeratoma circumscriptum.

  • Fig. 3 Intraoperative and postoperative views. A. The cheek lesion was excised, and the surgical defect was primarily closed with an advancement flap. B. Two months after the operation, the surgical site was healed uneventfully.

  • Fig. 4 Immunohistochemistry for vascular endothelial growth factor (VEGF) and both of its receptors (VEGFR-1 and VEGFR-2) (scale bars=100 µm). VEGF, VEGFR-1, and VEGFR-2 were expressed in endothelial cells and stromal cells in the lesion. Staining was stronger and the proportion of positive cells was higher for VEGFR-2 than for VEGFR-1. Several lesion cells co-expressed VEGF as well as VEGFR-1 and VEGFR-2 (arrows). In addition, some additional endothelial cells stained positive for VEGF and VEGFR-2, but not for VEGFR-1 (arrowheads). The coexpression of VEGF and its receptors suggests that VEGF is an autocrine growth factor for endothelial cells in the oral angiokeratoma circumscriptum lesion presented in this study.


Reference

1. Schiller PI, Itin PH. Angiokeratomas: an update. Dermatology. 1996; 193:275–282. PMID: 8993949.
Article
2. Ozdemir R, Karaaslan O, Tiftikcioglu YO, Kocer U. Angiokeratoma circumscriptum. Dermatol Surg. 2004; 30:1364–1366. PMID: 15458538.
Article
3. Vijaikumar M, Thappa DM, Karthikeyan K, Jayanthi S. Angiokeratoma circumscriptum of the tongue. Pediatr Dermatol. 2003; 20:180–182. PMID: 12657024.
Article
4. Varshney S. Angiokeratoma circumscriptum of the tongue. Int J Dermatol. 2005; 44:886–888. PMID: 16207201.
Article
5. Sion-Vardy N, Manor E, Puterman M, Bodner L. Solitary angiokeratoma of the tongue. Med Oral Patol Oral Cir Bucal. 2008; 13:E12–E14. PMID: 18167473.
6. Leung CS, Jordan RC. Solitary angiokeratoma of the oral cavity. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997; 84:51–53. PMID: 9247950.
Article
7. Kumar MV, Thappa DM, Shanmugam S, Ratnakar C. Angiokeratoma circumscriptum of the oral cavity. Acta Derm Venereol. 1998; 78:472. PMID: 9833054.
8. Bhargava P, Bhargava S, Mathur D, Agarwal US, Bhargava R. Angiokeratoma of tongue. Indian J Dermatol Venereol Leprol. 2001; 67:270. PMID: 17664774.
9. Siponen M, Penna T, Apaja-Sarkkinen M, Palatsi R, Salo T. Solitary angiokeratoma of the tongue. J Oral Pathol Med. 2006; 35:252–253. PMID: 16519775.
Article
10. Patigaroo S, Khan N, Manzoor S, Gupta N, Jain P, Shakeel M. Isolated multiple angiokeratoma of tongue--a case report and review of literature. Int J Pediatr Otorhinolaryngol Extra. 2012; 7:126–128.
Article
11. Green JB, Roy S. Angiokeratoma circumscriptum of the dorsal tongue in a child. Int J Pediatr Otorhinolaryngol Extra. 2006; 1:107–109.
Article
12. Erkal EY, Karabey MS, Vural Ç, Mutlu F, Aksu G, Sarper B, et al. Solitary angiokeratoma of the tongue in an adult patient treated with intensity modulated radiation therapy. Am J Otolaryngol. 2013; 34:582–585. PMID: 23410904.
Article
13. Mittal R, Aggarwal A, Srivastava G. Angiokeratoma circumscriptum: a case report and review of the literature. Int J Dermatol. 2005; 44:1031–1034. PMID: 16409270.
Article
14. Fabry J. Uber einen fall von angiokeratoma circumscriptum am linken oberschenkel. Derm Z. 1915; 22:1–4.
15. Kobayashi T, Sakuraoka K. A case of angiokeratoma circumscriptum: immunolocalization of matrix metalloproteinase (MMP)-9. J Dermatol. 1998; 25:391–394. PMID: 9675347.
Article
16. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 1999; 13:9–22. PMID: 9872925.
Article
17. Masood R, Cai J, Zheng T, Smith DL, Hinton DR, Gill PS. Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors. Blood. 2001; 98:1904–1913. PMID: 11535528.
Article
Full Text Links
  • JKAOMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr